-
Featured Authors
-
Archives
- May 2013
- April 2013
- March 2013
- February 2013
- January 2013
- December 2012
- November 2012
- October 2012
- September 2012
- August 2012
- July 2012
- June 2012
- May 2012
- April 2012
- March 2012
- February 2012
- January 2012
- December 2011
- November 2011
- October 2011
- September 2011
- August 2011
- July 2011
- June 2011
- May 2011
- April 2011
- March 2011
- February 2011
- January 2011
- December 2010
- November 2010
- October 2010
- September 2010
- August 2010
- July 2010
- June 2010
- May 2010
- April 2010
- March 2010
- February 2010
- January 2010
- December 2009
- November 2009
- October 2009
- September 2009
- August 2009
- July 2009
- June 2009
- May 2009
- April 2009
- March 2009
- February 2009
- January 2009
- December 2008
- November 2008
- October 2008
- September 2008
- August 2008
- July 2008
- June 2008
- May 2008
- April 2008
- March 2008
- February 2008
-
Meta
Monthly Archives: May 2012
2012 BIO International Convention Keynotes: Back to Basics
The 2012 BIO International Convention is a few short weeks away, and we are looking forward to this opportunity to come together for connections and partnerships that will lead to tomorrow’s breakthroughs. The Keynote Luncheon panels are always a highlight of the Convention. This year in Boston we decided to focus on core issues facing the global biotech community with keynote speakers and panelists who will provide timely insights on the economic, policy and business Read More >
IP Creates Jobs for America
By Mark Elliot, Executive Vice President, U.S. Chamber of Commerce’s Global Intellectual Property Center In May, the Global Intellectual Property Center (GIPC) was proud to unveil the results of our state intellectual property (IP) jobs research, which has been a year in the making. The study, IP Creates Jobs for America, provides real, tangible evidence that the economic benefits of IP are broad and far-reaching. In looking at a variety of government data on intellectual Read More >
ALS Awareness Month: 10 Things You Should Know About ALS
By Steve Perrin, Ph.D., Chief Executive Officer and CSO, ALS Therapy Development Institute May is a month full of many exciting and celebratory days: college graduations, Mother’s day and Memorial Day. It is a month typified by excitement, renewal, anticipation and remembrance. It is also the month in the United States where we recognize all those living with ALS, commonly known as Lou Gehrig’s disease. If you don’t know someone already living with this currently Read More >
Only a Few Public Biotechs are Profitable, but There are More of Them Today
Of the 294 biotechs trading on public exchanges today, 248 (84%) focus on drug development. Of these 248 in the biopharmaceutical space, 81, or 33% have a drug approved. Only 32 (13%) had both a product on the market and positive net income in 2011. However, this 13% represents a significant jump from the 7.5% with positive net income we calculated for 2009. Note that this comes over a time frame in which a few profitable companies were Read More >
The Scheduling Process
Scheduling for companies will kick into full gear the week of May 28th for the BIO Business Forum and participating exhibiting companies. As mentioned in a previous post, we wanted to discuss scheduling in a bit more detail, so that you understand what scheduling means, and how it impacts the way you use the Partnering System. First and foremost, meetings are only scheduled for those in Accepted/Agreed-To status. Your action item? Go in to your Read More >
